Argos Therapeutics to Participate in 23rd Annual NewsMakers in the Biotech Industry Conference
Sep 01, 2016 20:05 pm UTC| Business
DURHAM, N.C., Sept. 01, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of truly individualized immunotherapies based on the Arcelis®...
Vitae Pharmaceuticals to Present at Wells Fargo Healthcare Conference
Sep 01, 2016 20:05 pm UTC| Business
FORT WASHINGTON, Pa., Sept. 01, 2016 -- Vitae Pharmaceuticals, Inc. (NASDAQ:VTAE), a clinical-stage biotechnology company, today announced that Jeffrey Hatfield, President and Chief Executive Officer, will present a...
Meridian Bancorp, Inc. Announces Quarterly Dividend
Sep 01, 2016 20:05 pm UTC| Business
BOSTON, Sept. 01, 2016 -- The Board of Directors of Meridian Bancorp, Inc. (the “Company”) (NASDAQ:EBSB), the holding company for East Boston Savings Bank, today declared a quarterly cash dividend of $0.03 per common...
Sep 01, 2016 20:05 pm UTC| Business
TUSTIN, Calif., Sept. 01, 2016 -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology...
Broadcom Limited Announces Third Quarter Fiscal Year 2016 Financial Results and Interim Dividend
Sep 01, 2016 20:02 pm UTC| Business
Quarterly GAAP diluted loss per share of $0.75; Quarterly non-GAAP diluted earnings per share from continuing operations of $2.89Quarterly GAAP gross margin of 47.0 percent; Quarterly non-GAAP gross margin from continuing...
State National Companies Announces Quarterly Cash Dividend
Sep 01, 2016 20:02 pm UTC| Business
BEDFORD, Texas, Sept. 01, 2016 -- State National Companies, Inc. (NASDAQ:SNC) today announced that its Board of Directors has declared a regular cash dividend of $0.06 per share payable on its outstanding common stock....
SeaChange International Reports Second Quarter Fiscal 2017 Results
Sep 01, 2016 20:01 pm UTC| Business
ACTON, Mass., Sept. 01, 2016 -- SeaChange International, Inc. (NASDAQ:SEAC) today reported second quarter fiscal 2017 revenue of $18.5 million and U.S. GAAP loss from operations of $11.7 million, or $0.33 per basic...